Guardant Health (GH) Short-term Investments (2017 - 2026)

Guardant Health has disclosed Short-term Investments across 10 years of filings, most recently posting $113.5 million for Q1 2026.

• In Q1 2026, Short-term Investments changed N/A year-over-year to $113.5 million; the TTM figure through Mar 2026 stood at $113.5 million (changed N/A YoY), while the FY2025 annual figure was $823.4 million, up 161.86% from the prior year.
• Short-term Investments came in at $113.5 million for Q1 2026 at Guardant Health, down from $823.4 million in the prior quarter.
• In the past five years, Short-term Investments ranged from a high of $953.8 million in Q2 2023 to a low of $35.1 million in Q4 2023.
• Average Short-term Investments over 5 years is $554.9 million, with a median of $668.0 million recorded in 2022.
• Year-over-year, Short-term Investments tumbled 95.96% in 2023 and jumped 795.91% in 2024.
• Over 5 years, Short-term Investments stood at $869.6 million in 2022, then plunged by 95.96% to $35.1 million in 2023, then jumped by 795.91% to $314.4 million in 2024, then soared by 161.86% to $823.4 million in 2025, then tumbled by 86.22% to $113.5 million in 2026.
• Per Business Quant data, the three most recent Short-term Investments figures were $113.5 million in Q1 2026, $823.4 million in Q4 2025, and $314.4 million in Q4 2024.